INTRODUCTION
============

Group II introns are large ribozymes that catalyse their own excision from RNA transcripts through a process called splicing ([@B1; @B2; @B3]). Some group II introns that harbour an open reading frame (ORF) are also mobile retroelements, which are capable of invading new DNA sites using an RNA intermediate ([@B2]). Group II introns are found in bacteria, archaea and bacterial-derived organelles of lower eukaryotes and higher plants ([@B1]).

Splicing of group II introns is achieved by two consecutive transesterification reactions (A) ([@B2],[@B3]). The 2′-OH of a bulged adenosine (A) found near the 3′ end of the intron initiates the first nucleophilic attack on the exon 1--intron junction ([Figure 1](#F1){ref-type="fig"}A, step 1). This results in a 2′--5′ branching of the intron on the bulged adenosine and the release of exon 1. The liberated 3′-OH of exon 1 initiates the second nucleophilic attack on the intron--exon 2 junction ([Figure 1](#F1){ref-type="fig"}A, step 2), thereby releasing the intron in the form of a lariat and ligating the two exons. This splicing mechanism is identical to the removal of nuclear eukaryotic introns by the spliceosome, therefore suggesting a common origin for these two classes of introns ([@B1],[@B2],[@B4]). Figure 1.Group II intron splicing pathway and Ll.LtrB secondary structure. (**A**) Splicing pathway of group II introns. The 2′OH of the bulged adenosine present in domain VI of the intron (circled A) performs the initial nucleophilic attack on the exon 1--intron junction (step 1), generating a 2′--5′ linkage, also known as a branch point. Then, the 3′-OH of the released exon 1 performs the second nucleophilic attack on the intron--exon 2 junction (step 2), releasing the intron lariat and ligating the flanking exons. Group II intron, black line; exon 1 and 2, E1 and E2; branch point, circled A. (**B**) Schematic of the Ll.LtrB secondary structure. The six domains of Ll.LtrB are indicated (I--VI) and the detailed secondary structure of a portion of domain IV is shown (top right). The LtrA start and stop codons are boxed and the Shine--Dalgarno sequence is underlined. Exon 1 and 2 on both sides of the intron are also boxed. Pairs of greek letters, linked by dashed lines, correspond to long-range interactions between different portions of the intron. The five chosen Ll.LtrB fragmentation sites are mapped with black arrowheads (S1--S5). EBS1 and EBS2, exon-binding site 1 and 2; IBS1 and IBS2, intron-binding site 1 and 2; branch point, circled A.

Group II introns share very little sequence similarity. However, their secondary structure is universally conserved and is composed of six domains radiating from a central hub (e.g. [Figure 1](#F1){ref-type="fig"}B) ([@B1; @B2; @B3]). Domain I is transcribed first, and when folded, it provides the scaffold to dock the other folded intron domains ([@B5]). Domain IV plays little if any role in catalysis ([@B2],[@B3]) and was shown to be dispensable for splicing *in vitro* ([@B6]). In many cases, the loop region of domain IV contains an ORF expressing an intron-encoded protein (IEP), which provides essential functions for both intron splicing and mobility ([@B1; @B2; @B3],[@B7]). Domain V is the catalytic domain of these ribozymes and its sequence is the most conserved among group II introns ([@B1; @B2; @B3],[@B8]). Domain VI carries the branch point nucleotide, which is most often an adenosine. The structure of this domain is believed to place the branch point nucleotide near the 5′ splice site in a position that allows initiation of the first nucleophilic attack ([Figure 1](#F1){ref-type="fig"}A, step 1) ([@B8]).

In addition to local base pairing, a series of long-range interactions between the various folded domains were characterized (e.g. [Figure 1](#F1){ref-type="fig"}B, greek symbols) ([@B1; @B2; @B3],[@B8]). For instance, recognition of the exon--intron boundaries is achieved via long-range interactions between domain I and both exons. In general, domain I harbours the exon-binding sites 1 and 2 (e.g. [Figure 1](#F1){ref-type="fig"}B, EBS1 and EBS2), which are involved in 5′ splice site recognition through base pairing interactions with exon 1. The sequences of these exon-binding sites are complementary to contiguous intron-binding sites 1 and 2 located at the 3′ end of exon 1 (e.g. [Figure 1](#F1){ref-type="fig"}B, IBS1 and IBS2) ([@B3]). Similarly, the intron--exon 2 splice junction is recognized by either the δ--δ′ or EBS3--IBS3 interaction between domain I and exon 2 ([@B1],[@B3]). Another important long-range interaction, ζ--ζ′, links the GNRA tetraloop of domain V to a phylogenetically conserved stem-loop structure within domain I (e.g. [Figure 1](#F1){ref-type="fig"}B). This tertiary interaction is thought to form the intron catalytic core ([@B8],[@B9]). It was previously demonstrated that tertiary interactions allow the assembly and splicing of an intron fragmented within domain IV *in vitro*, even if no base pairing can take place between the two intron fragments ([@B6]).

Remarkably, the fragments of some group II introns that became fragmented by genome rearrangements in organelles have the capacity to re-assemble and splice accurately *in vivo* ([@B1],[@B9]). This phenomenon, known as trans-splicing, ligates exons expressed on two separate transcripts. Most fragmented group II introns are found interrupted within domain IV ([@B1],[@B9]). When these introns harbour an IEP within domain IV, the fragmentation site is located either upstream or downstream from the ORF. There are two examples of group II introns fragmented within domain III; they are found in the chloroplastic genomes of the liverwort *Marchantia polymorpha* and the tobacco plant *Nicotiana tabacum* ([@B10]). In addition, two tripartite group II introns, i.e. introns fragmented into three pieces, have been reported to functionally trans-splice in their respective hosts. The first example ligates exons 1 and 2 of the *psaA* chloroplast gene of the green alga *Chlamydomonas reinhardtii* ([@B11]). The second example joins exons c and d of the *nad5* subunit gene in mitochondria of the angiosperm plant *Oenothera berteriana* ([@B12]). These tripartite introns are both fragmented in domain I upstream of the EBS regions and in domain IV, which, in both cases, do not appear to contain an ORF.

The discovery of group II introns in bacteria greatly facilitated the study of their splicing and mobility pathways. One of the best characterized bacterial group II introns is Ll.LtrB, a 2.5-kb intron found in the low G + C Gram-positive bacterium *Lactococcus lactis*. It was the first bacterial group II intron shown to splice ([@B13]) and mobilize ([@B14]) *in vivo*. The splicing ([@B15; @B16; @B17; @B18]) and mobility pathways ([@B19; @B20; @B21; @B22]) of this intron have been extensively studied *in vivo*.

Ll.LtrB harbours an ORF in domain IV coding for a 599 amino acid protein, LtrA, with three enzymatic activities: reverse transcriptase, maturase and endonuclease ([@B23]). The maturase activity of LtrA is essential to promote intron splicing by assisting the folding of this large ribozyme into its catalytically active conformation ([@B19],[@B23]). LtrA binds the intron RNA primarily at a distinctive structure found in domain IVa ([Figure 1](#F1){ref-type="fig"}B, DIVa) ([@B16]). By binding to this structural motif, the IEP occludes its own Shine--Dalgarno sequence and autoregulates its translation ([@B24]).

The Ll.LtrB group II intron is found in three conjugative elements from *L. lactis*: the pRS01 ([@B13]) and pAH90 ([@B25]) plasmids, and the *L. lactis* 712 sex factor, an integrative and conjugative element closely related to pRS01 ([@B26]). Interestingly, in all three cases, the intron interrupts the gene coding for a putative relaxase at the same position. The relaxase enzyme is essential for conjugation; it initiates DNA transfer by inflicting a site and strand-specific nick at the origin of transfer (*oriT *) of the conjugative element. Then, the enzyme carries one DNA strand to the recipient cell by rolling-circle replication via the mating pore, and re-ligates the ends of the conjugated element ([@B27]).

Since the relaxase enzyme is essential for conjugation, splicing of Ll.LtrB is a prerequisite for the intercellular transfer of its host elements ([@B13],[@B26]). Klein and colleagues showed that the intimate relationship between splicing and conjugation can be exploited to monitor splicing of Ll.LtrB. They confirmed by real-time RT-PCR analyses that the conjugation efficiency of a mobilizable plasmid is directly proportional to splicing of Ll.LtrB from the relaxase transcript ([@B17]).

In this study, we use the Ll.LtrB intron from *L. lactis* as a model system to study group II intron trans-splicing in bacteria. We developed a splicing/conjugation assay that measures Ll.LtrB splicing efficiency by monitoring sex factor conjugation levels. We used this splicing/conjugation assay to investigate trans-splicing of the lactococcal intron. When fragmented at analogous locations to various naturally occurring fragmentation sites, Ll.LtrB consistently shows the ability to splice *in trans*, sometimes at very high efficiencies. Furthermore, we demonstrate that the LtrA protein is essential for trans-splicing. These findings constitute the first demonstration and characterization of trans-splicing of a group II intron in bacteria.

EXPERIMENTAL PROCEDURES
=======================

Strains and plasmids
--------------------

*Lactococcus lactis* strains NZ9800Δ*ltrB*::*tet* ([@B21]) and LM0231 ([@B28]) were grown at 30°C without shaking in M17 media supplemented with 0.5% glucose (GM17). *Escherichia coli* strain DH10β was used for cloning and was grown at 37°C by shaking in LB broth. Antibiotics were added at the following concentrations: 3 µg/ml for tetracycline (Tet), 300 µg/ml for spectinomycin (Spc), 25 µg/ml for fusidic acid (Fus) and 10 µg/ml for chloramphenicol (Cam).

Two 43-bp-long P~23~ constitutive promoters (P~23~ right and P~23~ left) ([@B29]) were obtained by annealing two complementary oligonucleotides (Supplementary Table S1, P~23~ right top/bottom, P~23~ left top/bottom). The pDL-P~23~^2^ plasmid was constructed by cloning, in opposite directions, the two P~23~ constitutive promoters within the pDL278 shuttle plasmid ([@B30]). The P~23~ left promoter is oriented towards the *rrnB* terminator (PvuI) while the P~23~ right promoter is directed towards the λ terminator (BamHI). The two promoters are 135 bp apart and initiate transcription in opposite orientations ([Figures 2](#F2){ref-type="fig"}A and [3](#F3){ref-type="fig"}B). When the oligonucleotides for P~23~ left were designed, a BssHII cloning site was introduced 6 nucleotides downstream of the transcription initiation site (Supplementary Table S1, P~23~ left top/bottom). Similarly, a NotI cloning site was introduced at the +6 position of P~23~ right (Supplementary Table S1, P~23~ right top/bottom). These two unique restriction sites were subsequently used to clone the various relaxase fragments. Figure 2.Ll.LtrB splicing/conjugation assay and relaxase expression levels. (**A**) Schematic of the Ll.LtrB splicing/conjugation assay. The *L. lactis* strain used as the donor strain harbours a sex factor that has a defective relaxase (NZ9800▵*ltrB*::*tet*) while the recipient strain lacks the sex factor (LM0231). The Ll.LtrB intron, along with portions of its exons, was replaced within the chromosomal sex factor by a tetracycline resistance marker, which prevents relaxase expression. The *ltrB* relaxase is constitutively produced from the pDL-P~23~^2^-*ltrB* complementation plasmid. When *ltrB* is interrupted by a splicing proficient variant of Ll.LtrB, relaxase is produced and mediates transfer of the sex factor from the donor to the recipient cell. The level of sex factor conjugation observed is proportional to the Ll.LtrB splicing efficiency. (**B**) Relaxase expression and Ll.LtrB splicing. Northern blots were performed using total RNA from NZ9800 and NZ9800Δ*ltrB* harbouring different pDL-P~23~^2^-based constructs. The amounts of total relaxase RNA (left) and mature relaxase transcript (right) produced were assessed (two independent blots, RNA was loaded in duplicate on the same gel). The exon 2 probe (left panel) (Supplementary Table S1, RT E2) and the splice-junction probe (right panel) (Supplementary Table S1, SJ) are depicted as grey bars. As an RNA loading control, the two membranes were stripped and probed with a 23S rRNA specific probe (Supplementary Table S1, 23S rRNA). (**C)** Western blot on total protein extracts using LtrB-specific antibodies. Ll.LtrB group II intron, black line; exon 1 and 2, E1 and E2; branch point, circled A; sex factor, grey; tetracycline resistance marker, Tet; spectinomycin resistance marker, Spc; P~23~ promoter, P~23~; transcription terminator, schematic stem-loop; *L. lactis* chromosome, scribble. Figure 3.Ll.LtrB trans-splicing/conjugation assay. (**A)** Strategy to generate a variant of Ll.LtrB fragmented at the Sn site (S1--S5). The relaxase gene is amplified as two non-overlapping fragments using the indicated primers (thick arrows, Supplementary Table S1). Each fragment is cloned under the control of a P~23~ promoter on pDL-P~23~^2^. (**B)** Ll.LtrB trans-splicing/conjugation assay. The pDL-P~23~^2^-Sn plasmid is transformed in NZ9800Δ*ltrB*. If the two fragments of the intron can correctly fold, assemble and trans-splice, the *ltrB* exons are ligated allowing the production of relaxase, which is required for sex factor transfer. Ll.LtrB splicing efficiency is monitored by the level of sex factor conjugation from the donor (NZ9800Δ*ltrB*) to the recipient *L. lactis* strain (LM0231). Ll.LtrB group II intron, thick black line; exon 1 and 2, E1 and E2; branch point, circled A; sex factor, grey; tetracycline resistance marker, Tet; spectinomycin resistance marker, Spc; P~23~ promoters, P~23~; transcription terminators, schematic stem-loops; *L. lactis* chromosome, scribble.

The pDL-P~23~^2^-*ltrB* plasmid was obtained by cloning the promoter-less *ltrB* gene in pDL-P~23~^2^ under the control of P~23~ right. The *ltrB* gene was PCR-amplified from genomic DNA extracted from the sex factor-containing *L. lactis* strain NZ9800 ([@B31]) using the 5′*ltrB* and 3′*ltrB* primers (Supplementary Table S1). To generate the intron-mutated versions of this plasmid, the BsrGI/HpaI fragment spanning most of the Ll.LtrB intron and a portion of the *ltrB* exon 2 was exchanged for the corresponding fragment from pLE12ΔD5, pLE12ΔORF and pLE12Mat^−^, respectively ([@B23],[@B31]).

The pLE-P~23~^2^ plasmid was generated by cloning the 1.8-kb SapI fragment from pDL-P~23~^2^ containing the divergent P~23~ transcriptional units, into the unique SmaI site of the pLE1 plasmid ([@B28]). The resulting plasmid was used for expression of two of the three intron pieces when assessing tripartite variants of Ll.LtrB, and for overexpression of LtrA in ORF-complementation assays. For the latter experiments, the *ltrA* gene was PCR-amplified using primers 5′*ltrA* and 3′*ltrA* (Supplementary Table S1), and cloned in the NotI restriction site of pLE-P~23~^2^.

To generate fragmented variants of Ll.LtrB, the sites of fragmentation, Sn ([Figure 1](#F1){ref-type="fig"}B, S1--S5), were chosen according to the occurrence of fragmented group II introns in nature. Two primers were designed for each Sn fragmentation site. The Sn-P1 primer was always used in conjunction with the 5′*ltrB* primer to generate the 5′ fragment of the relaxase by PCR amplification ([Figure 3](#F3){ref-type="fig"}A). Similarly, the Sn-P2 primer was always used with the 3′*ltrB* primer to generate the 3′ fragment of the relaxase ([Figure 3](#F3){ref-type="fig"}A). The 5′ and 3′ fragments were cloned downstream from the P~23~ right and P~23~ left promoters, respectively. All relaxase fragments were PCR-amplified from genomic DNA of the sex factor-containing *L. lactis* strain NZ9800 ([@B31]). To generate the maturase-mutated and ΔORF variants of fragmented Ll.LtrB constructs, the ORF-containing intron fragment was PCR-amplified from the pLE12Mat^−^ and pLE12ΔORF plasmids, respectively. The sequence integrity of all relaxase fragments generated by PCR amplification was confirmed by sequence analyses.

Conjugation assays
------------------

Mating was performed on milk plates made of 5% non-fat dried milk (Carnation™), 1% glucose and 1.5% agar ([@B31]). Donor and recipient *L. lactis* strains were inoculated from saturated overnight cultures (0.4 ml into 10 ml), and grown for 7 h. Cells were then collected by centrifugation, mixed and spread on milk plates. After a 16-h incubation at 30°C, cells were recovered in 1 ml 1X PBS, and appropriate dilutions were plated on selective medium for donors, recipients and transconjugants. Conjugation efficiencies were calculated as the ratio of transconjugant cells (Fus^R^/Tet^R^) to donor cells (Spc^R^), for three independent assays. The *L. lactis* strains NZ9800Δ*ltrB*::*tet* and LM0231 (Fus^R^) were used as the donor and recipient strains, respectively.

RNA isolation, northern blot hybridizations and RT-PCR
------------------------------------------------------

Total RNA was isolated from *L. lactis* cells inoculated from saturated overnight cultures (0.4 ml into 10 ml), and grown for 7 h. Cell pellets were mixed with 500 ml TRIzol (Invitrogen life technologies) and 250 µg of acid-washed glass beads (Sigma). The mixture was vortexed for 3 min and incubated at 55°C for 5 min; this treatment was repeated three times. The rest of the extraction was performed according to the TRIzol manufacturer\'s protocol.

For northern blot hybridization, 10 μg of total RNA was resolved on 1% agarose gel containing 5% formaldehyde and transferred by capillarity to nylon membrane (Hybond-N; Amersham Biosciences). The membranes were hybridized with the appropriate 5′-^32^P labelled oligonucleotide probe (see figure legends and Supplementary Table S1). Radiolabelling of the probes was performed in a final volume of 10 μl containing 10 pmol of the oligonucleotide, 6.4 pmol of \[γ-^32^P\]ATP (6000 Ci/mmol; Amersham Biosciences) and 5 U of T4 polynucleotide kinase (New England Biolabs) at 37°C for 1 h. The labelling mix was then purified on Sephadex G-50 columns. The membranes were hybridized for 2 h at 42°C, washed and exposed on a phosphor screen, which was visualized with the Molecular Imager FX software from Bio-Rad. As an RNA loading control, the membranes were stripped and re-probed with an oligonucleotide specific for the 23S rRNA of *L. lactis* ([Figure 2](#F2){ref-type="fig"}C).

For reverse transcriptase (RT)-PCR analyses, cDNAs were synthesized using the SuperScript II cDNA synthesis kit from Invitrogen according to the manufacturer\'s instructions, using 5 µg of total RNA and 2 pmol of the appropriate primer. The BP cDNA primer was used to synthesize cDNA across the Ll.LtrB branch point, while the E2 cDNA primer was used to synthesize cDNA of the *ltrB* ligated exons (Supplementary Table S1). PCR amplification was performed using 10% of the cDNA obtained and 2 U of Taq DNA polymerase (New England Biolabs).

Protein isolation and western blot
----------------------------------

Total proteins were extracted from *L. lactis* cells grown to mid-log phase. Cells were pelleted and resuspended in 100 µl TES buffer (10 mM Tris-HCl pH 8.0, 1 mM EDTA, 25% sucrose) containing 1 mg/ml lysozyme (Roche), 50 U/ml mutanolysin (Sigma®) and 0.1 mg/ml RNaseA (USB). This mixture was incubated for 1 h at 37°C. Cells were then lysed by mixing with 100 µl 1X TE buffer containing 4% SDS and boiling for 5 min. Samples were loaded on SDS-PAGE (10%) by mixing 10 µl of the total protein extract with 10 µl of SDS loading buffer containing 5% β-mercaptoethanol.

For western blot analysis, the gel was transferred electrophoretically onto PVDF membrane (Immobilon-P, Millipore). The membrane was blocked O/N in 1X PBS---0.1% Tween 20 (Fisher) (PBS-T) containing 10% non-fat dried milk (Carnation™). Anti-LtrB antibodies ([@B18]) were subjected to a membrane containing protein extracts from *L. lactis* cells not expressing LtrB to reduce the amounts of antibodies reactive to non-LtrB proteins, like previously described ([@B15]). Following blocking, the membrane containing the samples for analysis was incubated 1 h in PBS-T + 5% milk containing 1:5000 depleted anti-LtrB antibodies. After three 5-min washes in PBS-T, the membrane was incubated 1 h in PBS-T containing horseradish peroxidase (HRP)-conjugated anti-rabbit antibody (1:30 000; Bio-Rad), then washed four times for 5 min in PBS-T. The membrane was detected with Immobilon™ Western Chemiluminescent HRP Substrate (Millipore) and visualized with the Molecular Imager VersaDoc from Bio-Rad and on X-ray film. The software Quantity One® (Bio-Rad) was used for quantitative analysis of LtrB amounts.

RESULTS
=======

A conjugation-based system to monitor Ll.LtrB splicing
------------------------------------------------------

We developed a genetic assay to monitor Ll.LtrB splicing by measuring the conjugation efficiency of the chromosomal sex factor between *L. lactis* strains ([Figure 2](#F2){ref-type="fig"}A). This splicing/conjugation assay exploits the dependence of conjugative transfer of the sex factor on Ll.LtrB splicing from the relaxase transcript ([@B17],[@B26]). The sex factor donor strain used in this assay is NZ9800Δ*ltrB*::*tet*, in which the sex factor carries a deletion of the Ll.LtrB intron and portions of its flanking exons destroying the relaxase gene ([@B21]). In the absence of relaxase, the sex factor transfer efficiency drops from 7.33 × 10^−3^ ([@B32]) to 1.88 × 10^−9^ ([Table 1](#T1){ref-type="table"}, cf. SF wild-type and SFΔ*ltrB/*pDL-P~23~^2^). Table 1.Sex factor conjugation efficiencies observed with different relaxase variantsDonor strainSF variant/complementation plasmidSF conjugation efficiencyNZ9800SF wild-type[^a^](#TF1){ref-type="table-fn"}(7.33 ± 0.58) × 10^−3^NZ9800Δ*ltrB*SFΔ*ltrB*(1.88 ± 1.96) × 10^−9^NZ9800Δ*ltrB*SFΔ*ltrB/*pDL-P~23~^2^-*ltrB*(5.80 ± 2.89) × 10^−2^NZ9800Δ*ltrB*SFΔ*ltrB/*pDL-P~23~^2^-*ltrB* ΔD5(3.79 ± 1.75) × 10^−9^NZ9800Δ*ltrB*SFΔ*ltrB/*pDL-P~23~^2^-*ltrB* ΔORF(1.93 ± 0.96) × 10^−8^NZ9800Δ*ltrB*SFΔ*ltrB/*pDL-P~23~^2^-*ltrB* Mat^−^(2.86 ± 0.86) × 10^−4^[^1][^2]

A complementation system was built where the intron-interrupted *ltrB* gene was cloned in the pDL-P~23~^2^ plasmid and expressed under the control of the P~23~ constitutive promoter ([Figure 2](#F2){ref-type="fig"}A, pDL-P~23~^2^-*ltrB*). When the relaxase-deleted sex factor is thereby complemented, transfer efficiency is restored from 1.88 × 10^−9^ to 5.80 × 10^−2^ ([Table 1](#T1){ref-type="table"}, SFΔ*ltrB*/pDL-P~23~^2^-*ltrB*). The difference in transfer efficiency between the complemented (5.80 × 10^−2^) and the wild-type sex factor (7.33 × 10^−3^) (∼8-fold) is likely due to overexpression of the relaxase gene from a constitutive promoter on a multiple copy plasmid. Notably, the relaxase transcript produced from the wild-type chromosomal sex factor is undetectable by northern blot. On the other hand, expression from the P~23~ promoter produces high levels of both the full-length relaxase transcript and mature mRNA ([Figure 2](#F2){ref-type="fig"}B, compare lanes NZ9800 and *ltrB*-WT in both blots). Accordingly, significantly less ligated exons and no intron lariats are detected by RT-PCR in NZ9800, where the chromosomal sex factor expresses a functional relaxase, compared to expression of the relaxase gene from the P~23~ promoter (see below, [Figure 4](#F4){ref-type="fig"}B and C, cf. NZ9800 and *ltrB*-WT). Western blot analysis confirms the significant increase in LtrB production from the plasmid when compared to its expression from the chromosomal sex factor ([Figure 2](#F2){ref-type="fig"}C, cf. NZ9800 and *ltrB*-WT). Since no signal for LtrB is detected from NZ9800, the increase in LtrB expression from the P~23~ promoter was estimated to be of at least 112-fold. Therefore, the slight increase in conjugation efficiency between the wild-type and complemented sex factor (∼8-fold) is not comparable to the great difference in levels of relaxase expression observed (at least 112-fold). The complementation system is thus most likely saturated in relaxase enzyme, and the maximal rate of sex factor conjugation efficiency is probably reached (10^−2^ range). This suggests that the conjugation efficiency observed for the complemented sex factor underestimates the real splicing efficiency of Ll.LtrB. Therefore, the conjugation efficiencies observed throughout this study will be interpreted as increases from the background level rather than decreases from the saturated maximum level. Figure 4.RT-PCR analyses of excised Ll.LtrB introns and ligated exons. (**A**) Schematic of Ll.LtrB splicing (top) and trans-splicing (bottom). Primers used for RT-PCR amplifications of released intron lariats or Y-branched molecules are shown as black arrows (BP1 and 2). Ligated exons were amplified by RT-PCR with the RTE1 and 2 primers (open arrows). Agarose gels showing the RT-PCR amplification of Ll.LtrB across the branch point (**B**) and across the *ltrB* ligated exons (**C**) are presented. RT-PCR analyses were performed on total RNA extracts from NZ9800 or NZ9800Δ*ltrB* harbouring different pDL-P~23~^2^ plasmids expressing *ltrB* in one (WT, ΔD5) or two pieces (S1--S5). S3ΔORF and S4ΔORF represent the ΔORF variant of the S3 and S4 constructs without LtrA complementation. Ll.LtrB group II intron, black line; exon 1 and 2, E1 and E2; branch point, circled A.

To verify the dependence of sex factor conjugation on Ll.LtrB splicing, we tested an Ll.LtrB variant where the catalytic domain, i.e. domain V, was deleted (pDL-P~23~^2^-*ltrB*-ΔD5) ([@B23]). Complementation with a relaxase gene harbouring the catalytically inactive intron failed to sustain sex factor transfer; the conjugation efficiency observed was only 3.79 × 10^−9^ ([Table 1](#T1){ref-type="table"}, SFΔ*ltrB*/pDL-P~23~^2^-*ltrB*-ΔD5). This conjugation efficiency is similar to the background level observed for the *ltrB*-deficient sex factor ([Table 1](#T1){ref-type="table"}, SFΔ*ltrB*/pDL-P~23~^2^). Northern blot analyses of total RNA extracted from donor cells harbouring the pDL-P~23~^2^-*ltrB*-ΔD5 plasmid showed accumulation of the pre-mRNA precursor while no traces of ligated exons was detected ([Figure 2](#F2){ref-type="fig"}B, lane *ltrB*-ΔD5 in both blots). Accordingly, neither ligated exons nor excised intron lariats were detected by RT-PCR analyses (see below, [Figure 4](#F4){ref-type="fig"}B and C respectively). Taken together, these results demonstrate that transfer of the *L. lactis* sex factor is dependent on Ll.LtrB splicing from the relaxase transcript. We have therefore built a highly sensitive splicing/conjugation assay (10^7^-fold detection range) to monitor Ll.LtrB splicing in *L. lactis*.

Trans-splicing of Ll.LtrB fragmented within domain IV
-----------------------------------------------------

We used the above splicing/conjugation assay to assess if Ll.LtrB is capable of splicing when severed into two fragments at various positions. Several locations were chosen to mimic fragmentation sites found in naturally occurring trans-splicing group II introns ([Figure 1](#F1){ref-type="fig"}B, S1--S5). To introduce a fragmentation site within Ll.LtrB (Sn, n varies from 1 to 5), the complete relaxase gene was PCR-amplified as two non-overlapping fragments ([Figure 3](#F3){ref-type="fig"}A). To ensure equimolar production of each relaxase fragment, these were expressed from two constitutive P~23~ promoters located on the same plasmid, pDL- P~23~^2^ ([Figure 3](#F3){ref-type="fig"}B). The two promoters were cloned in opposite orientation to ensure that two independent RNA transcripts are generated. Proper expression of relaxase fragments was assessed by northern blot analyses and all the transcripts displayed the expected size. However, the fragments expressed from the P~23~-right promoter, consisting of exon 1 and the first portion of the Ll.LtrB intron, invariably showed slightly higher expression level than those expressed from the P~23~-left promoter, corresponding to the second portion of Ll.LtrB and exon 2 (data not shown). The lower expression of the 3′ relaxase fragments is likely due to their instability since transcription of these fragments is initiated at different positions within Ll.LtrB. This probably leads to a slight underestimation of the Ll.LtrB trans-splicing efficiency.

Most trans-splicing group II introns are found fragmented within domain IV. When these introns harbour an ORF, the fragmentation site can be found either upstream or downstream of the ORF. Therefore, we investigated the effect of fragmenting Ll.LtrB in domain IV, either upstream or downstream of the *ltrA* ORF. Two sites were chosen for fragmentation upstream of the ORF. The first site lies at the bottom of the DIV stem (position 524, [Figure 1](#F1){ref-type="fig"}B, S1). Fragmentation of Ll.LtrB at this location does not allow base pairing interactions between the two intron RNA pieces, but leaves only a series of long-range tertiary interactions for intron fragment recognition and assembly ([Figure 1](#F1){ref-type="fig"}B, greek letters). The second site lies within the DIVa stem at position 543 ([Figure 1](#F1){ref-type="fig"}B, S2). According to the potential tertiary contacts between the two Ll.LtrB fragments, this fragmentation site is equivalent to S1. However, S2 also allows a potential 16 base pair interaction between the two intron pieces. When the intron is fragmented at the S1 site, the relaxase can promote sex factor conjugation to an efficiency of 1.66 × 10^−6^, ∼890-fold over the background ([Figure 5](#F5){ref-type="fig"}, S1). This shows that tertiary interactions are sufficient to promote intron fragment assembly and splicing. On the other hand, when the relaxase is fragmented at the S2 site, sex factor conjugation is ∼87 times more efficient than S1, ∼76 000-fold over the background (1.44 × 10^−4^) ([Figure 5](#F5){ref-type="fig"}, S2). These results suggest that base pairing interactions between intron fragments further stimulate their assembly and splicing *in vivo*. Figure 5.Sex factor conjugation efficiencies observed with different fragmented variants of Ll.LtrB. The fragmentation sites within Ll.LtrB correspond to those shown in [Figure 1](#F1){ref-type="fig"}B (S1--S5). The Ll.LtrB variant column indicates which fragment(s) was/were overexpressed from the pDL-P~23~^2^ plasmid, and which mutated version of the ORF was used when applicable. The ΔORF + ORF variants correspond to the assays where LtrA was overexpressed from a second plasmid to complement the deleted version within Ll.LtrB. The schematics show linear representations of Ll.LtrB and its six domains (I--VI), and the location of the fragmentation sites. Sex factor conjugation efficiency is the average of three independent assays and the error is the standard deviation of the three obtained values. Ll.LtrB group II intron, black line; exon 1 and 2, empty boxes; branch point, circled A.

Fragmentation of Ll.LtrB in domain IV downstream of the ORF was also tested. The intron was fragmented downstream from the *ltrA* stop codon at position 2375, which allows a potential 15 base pair interaction between the two intron fragments ([Figure 1](#F1){ref-type="fig"}B, S3). Even though the potential tertiary interactions between the two intron pieces are the same as with S1 and S2, this Ll.LtrB trans-splicing variant harbours *ltrA* and the high affinity LtrA binding site ([Figure 1](#F1){ref-type="fig"}B, DIVa) on the 5′ instead of the 3′ intron fragment. The relaxase gene fragmented at the S3 site promoted sex factor conjugation to very high levels (1.16 × 10^−2^) ([Figure 5](#F5){ref-type="fig"}, S3, two fragments), ∼6.17 million-fold over the background ([Table 1](#T1){ref-type="table"}, SFΔ*ltrB*/pDL-P~23~^2^). Moreover, when the two relaxase pieces were expressed independently, sex factor conjugation remained near basal levels (10^−8^), showing a slight increase compared to the background ([Figure 5](#F5){ref-type="fig"}, S3, 5′ fragment and 3′ fragment). Therefore, expression of both relaxase fragments is absolutely required to promote sex factor conjugation. Taken together, these results demonstrate that when the Ll.LtrB intron is fragmented independently at three different positions within domain IV, a significant proportion of the two intron fragments can fold correctly, assemble and trans-splice to ligate their flanking exons.

Trans-splicing of Ll.LtrB fragmented at other naturally occurring group II intron fragmentation sites
-----------------------------------------------------------------------------------------------------

Fragmentation sites outside domain IV can be found in domains I or III in some group II introns. The next Ll.LtrB trans-splicing variant that we analysed mimics the fragmentation site in domain I of the tripartite intron from the *psaA* chloroplast gene of the green algae *C. reinhardtii* ([@B11]). The fragmentation site was introduced at position 172 upstream of the EBS1 and 2 sequences. When Ll.LtrB is fragmented at this position, the possible tertiary interactions contributing to intron fragment assembly are different from those of the previous fragmentation sites (S1--S3). Moreover, a potential 19 base pair interaction can take place between the two fragments of the intron ([Figure 1](#F1){ref-type="fig"}B, S4). When the two relaxase fragments are expressed independently, no significant increase in conjugation efficiency is observed (10^−8^ range) ([Figure 5](#F5){ref-type="fig"}, S4, 5′ fragment and 3′ fragment). However, when both fragments are co-expressed, the rate of sex factor conjugation increases to 4.52 × 10^−4^ ([Figure 5](#F5){ref-type="fig"}, S4, two fragments). The substantial increase observed (∼240 000-fold) in sex factor transfer efficiency from basal level when both relaxase fragments are produced demonstrates that Ll.LtrB can also trans-splice when fragmented in domain I at this position.

The last fragmentation site engineered in Ll.LtrB lies in the loop region of domain III at position 499 ([Figure 1](#F1){ref-type="fig"}B, S5) and mimics the fragmentation site of the *rps12* intron in *M. polymorpha* and *N. tabacum* chloroplasts ([@B10]). Fragmentation of Ll.LtrB at this location allows the same tertiary contacts between the two intron fragments as the S1, S2 and S3 sites. Moreover, 17 base pairs could be formed between the two intron fragments. When the *ltrB* gene is fragmented at this position, the amount of relaxase produced supports sex factor transfer to a level of 6.03 × 10^−5^ ([Figure 5](#F5){ref-type="fig"}, S5), which represents an increase of approximately 32 000-fold over the background level.

These results demonstrate that when the intron is fragmented within domains I or III, a significant proportion of the two independently expressed Ll.LtrB fragments can fold correctly, assemble, splice *in trans*, and ligate their flanking exons.

Detection of trans-spliced intron molecules and ligated exons by RT-PCR
-----------------------------------------------------------------------

Excised group II intron lariats can be detected from total RNA extracts by RT-PCR across the branch point ([Figure 4](#F4){ref-type="fig"}A, top, black arrows) ([@B33]). Using a similar approach, we designed an RT-PCR assay to detect the trans-spliced Y-shaped intron molecules ([Figure 4](#F4){ref-type="fig"}A, bottom). This assay was designed to yield a 201-bp fragment when a lariat or a Y-shaped intron molecule is produced. The two RT-PCR primers lie outside of the region where the fragmentation sites were engineered, and could thus be used with all fragmented relaxase variants ([Figure 4](#F4){ref-type="fig"}A, bottom, black arrows). The assay was performed on total RNA extracted from donor cells (NZ9800Δ*ltrB*) containing various Ll.LtrB constructs. As shown in [Figure 4](#F4){ref-type="fig"}B, donor cells harbouring the full-length relaxase gene yield a unique RT-PCR product of the expected size, representing the Ll.LtrB lariat ([Figure 4](#F4){ref-type="fig"}B, *ltrB*-WT). On the other hand, Y-branched intron molecules are only detected with the most efficient trans-splicing construct, where the intron is fragmented downstream of the ORF ([Figure 5](#F5){ref-type="fig"}, S3, two fragments). Failure to detect Y-branched introns from the other fragmented variants of Ll.LtrB is most likely due to the low level of these molecules as well as their instability. Indeed, Y-shaped molecules have three free ends and are more likely sensitive to degradation than intron lariats ([Figure 4](#F4){ref-type="fig"}A, bottom).

The presence of ligated exons of the relaxase gene was also assessed by RT-PCR. This assay was designed to produce a 521-bp fragment when the exons are properly ligated ([Figure 4](#F4){ref-type="fig"}A, open arrows). As can be seen in the agarose gel presented in [Figure 4](#F4){ref-type="fig"}C, ligated exons are detected in total RNA extracted from all donor cells containing Ll.LtrB constructs that showed conjugation efficiencies above background. Specifically, ligated exons are detected in the case of the full-length *ltrB* gene but not from the catalytically inactive *ltrB*-ΔD5 variant ([Figure 4](#F4){ref-type="fig"}C, *ltrB*-WT and *ltrB*-ΔD5). Ligated exons are also detected in all five cases of Ll.LtrB trans-splicing ([Figure 4](#F4){ref-type="fig"}C, S1--S5). Sequence analyses of all RT-PCR products confirmed that the exons were ligated precisely at the intron splice junctions. These RT-PCR assays confirm that in all cases where sex factor conjugation increased over the background, properly ligated relaxase exons were readily detectable in donor cells. Furthermore, Y-branched intron molecules could be detected only for the fragmented relaxase construct that sustains the highest conjugation efficiency (S3).

The LtrA protein is essential for trans-splicing of Ll.LtrB
-----------------------------------------------------------

Splicing of group II introns *in vivo* requires the assistance of splicing co-factors that function as maturases to stabilize the catalytically active intron structure ([@B2]). Some group II introns, like Ll.LtrB, encode their own maturase. The role of IEPs in trans-splicing has never been investigated.

To assess the role of the LtrA protein in Ll.LtrB trans-splicing, we studied two different protein mutants. First, the Ll.LtrB-Mat^−^ mutant carries point mutations that only affect the maturase activity of LtrA ([@B23]). Second, the Ll.LtrB-ΔORF intron carries a deletion of 88% of the *ltrA* coding sequence, which completely removes the maturase domain ([@B23]).

Cis-splicing of these Ll.LtrB mutants was first analysed in our splicing/conjugation assay. As expected, the Ll.LtrB-ΔORF mutant appears completely inactive. When the relaxase gene harbours this intron mutant, sex factor conjugation efficiency is only 10-fold higher than the background ([Table 1](#T1){ref-type="table"}, cf. SFΔ*ltrB*/pDL-P~23~^2^-*ltrB* ΔORF and SFΔ*ltrB*/pDL-P~23~^2^). Surprisingly, the maturase mutant efficiently induced sex factor transfer to a level ∼152 000-fold over the background ([Table 1](#T1){ref-type="table"}, cf. SFΔ*ltrB*/pDL-P~23~^2^-*ltrB* Mat^−^ and SFΔ*ltrB*/pDL-P~23~^2^). Such a result suggests that this LtrA mutant can still bind and promote Ll.LtrB splicing.

Next, the two LtrA mutants were analysed in the context of two fragmented introns: the S4 variant fragmented within domain I, and the S3 variant fragmented downstream of the ORF within domain IV. These two introns were chosen because they trans-splice efficiently and are fragmented in different domains (DI versus DIV). The intron fragment that is bound by the LtrA protein also differs in these two variants. Indeed, when the intron is fragmented within domain I (S4), the LtrA primary-binding site (stem DIVa, [Figure 1](#F1){ref-type="fig"}B) lies in the 3′ fragment of the intron. On the other hand, when the fragmentation site is located downstream of the ORF (S3), the LtrA primary binding site lies in the 5′ fragment of the intron ([Figure 1](#F1){ref-type="fig"}B). As shown in [Figure 5](#F5){ref-type="fig"}, the introduction of point mutations, that only abolish the maturase activity of LtrA to both fragmented introns, caused a consistent decrease of ∼35 000-fold in sex factor conjugation efficiency ([Figure 5](#F5){ref-type="fig"}, S4 and S3, two fragments/Mat^−^). Moreover, removal of the ORF from Ll.LtrB completely abolishes trans-splicing as the sex factor conjugation efficiency drops to background levels with both variants tested (10^−9^) ([Figure 5](#F5){ref-type="fig"}, S3 and S4, two fragments/ΔORF). Interestingly, if a second plasmid overexpressing LtrA (pLE-P~23~^2^-*ltrA*) is introduced into cells harbouring the ΔORF variants of fragmented Ll.LtrB, conjugation efficiency is almost completely restored ([Figure 5](#F5){ref-type="fig"}, S3 and S4, two fragments/ΔORF + ORF). This increase in sex factor conjugation efficiency is not a direct effect of LtrA on the sex factor since the LtrA-expressing plasmid alone does not sustain conjugation of the sex factor (1.31 ± 0.85 × 10^−9^). These results demonstrate that the LtrA protein, primarily through its maturase function, is an essential co-factor for Ll.LtrB trans-splicing in *L. lactis*.

DISCUSSION
==========

In this study, we describe a highly sensitive conjugation-based system to monitor splicing of the Ll.LtrB group II intron in *L. lactis*. One of the important features of this experimental system lies in its extremely broad detection range. This simple genetic assay allows the detection and study of Ll.LtrB splicing quantitatively on a 10^7^-fold detection range. As we demonstrate in this study, the Ll.LtrB splicing/conjugation assay will be particularly useful to study group II intron trans-splicing, an aspect of group II intron splicing that is not very well studied or understood.

Although this genetic assay was developed to study Ll.LtrB trans-splicing, some interesting facts regarding sex factor conjugation and Ll.LtrB cis-splicing were discovered. First, we observe that expressing higher amounts of the relaxase enzyme increased sex factor conjugation efficiency from 7.33 × 10^−3^ ([@B32]) to 5.80 × 10^−2^ ([Table 1](#T1){ref-type="table"}). Our data show that the sex factor conjugation machinery can sustain even higher transfer rates than what is observed with the wild-type element. This demonstrates that the presence of Ll.LtrB within the relaxase gene not only controls conjugation of the *L. lactis* sex factor, but also that the normal LtrB expression level in NZ9800 is sub-optimal for the sex factor conjugation machinery. This suggests that any mutation within Ll.LtrB that hinders splicing would also directly, and proportionally, reduce LtrB expression and sex factor conjugation efficiency.

The catalytic domain (DV) of Ll.LtrB was previously deleted to generate a splicing deficient mutant ([@B23]). When the relaxase gene contains this Ll.LtrB-ΔD5 variant, the sex factor conjugation efficiency is similar to the background observed when no relaxase is provided *in trans* ([Table 1](#T1){ref-type="table"}, 3.79 × 10^−9^ versus 1.88 × 10^−9^). Moreover, no RT-PCR signals for excised intron lariats or ligated exons were obtained for this Ll.LtrB mutant ([Figure 4](#F4){ref-type="fig"}B and C). Taken together, these results confirm that deletion of domain V from Ll.LtrB prevents any residual splicing in *L. lactis*.

When the relaxase gene provided *in trans* is interrupted by the Ll.LtrB maturase-deficient mutant (Ll.LtrB-Mat^−^), sex factor conjugation efficiency increases by ∼152 000-fold over the background ([Table 1](#T1){ref-type="table"}, 2.86 × 10^−4^ versus 1.88 × 10^−9^). This shows that this LtrA maturase mutant can bind the intron and promote splicing to significant levels. When Ll.LtrB is missing most of the LtrA coding region (Ll.LtrB-▵ORF), we observe only a minor increase in sex factor conjugation efficiency ([Table 1](#T1){ref-type="table"}). In fact, this increase is comparable to the background conjugation rate obtained upon expression of individual fragments of the relaxase variants fragmented at position S3 and S4 ([Figure 5](#F5){ref-type="fig"}, S3/5′ fragment and 3′ fragment, S4/5′ fragment and 3′ fragment). Conjugation efficiencies in the 10^−8^ range correspond to only a few transconjugant colonies per assay; very close to the limit of detection of our system.

Using our splicing/conjugation assay, we report the first experimental evidence that group II introns can trans-splice in bacteria. All the naturally occurring group II intron fragmentation sites were independently engineered within Ll.LtrB: three sites located in domain IV, two upstream and one downstream of the ORF, and one site located in both domains I and III. The trans-splicing efficiency of Ll.LtrB was found to vary greatly with the location of the fragmentation site ([Figure 5](#F5){ref-type="fig"}). Considering the limited number of characterized trans-splicing introns and the lack of similarity between these introns and Ll.LtrB, it was surprising to detect trans-splicing with all fragmented variants of the lactococcal intron. The fragmentation site we engineered in domain I was actually never found as a unique fragmentation site. It was only observed in nature in conjunction with a second fragmentation within domain IV in two tripartite group II introns ([@B11],[@B12]). Nevertheless, when fragmented at this location within domain I, Ll.LtrB trans-splices efficiently since the sex factor conjugation is ∼240 000-fold higher than the background.

In domain IV, two different intron fragmentation sites upstream of the *ltrA* coding region were studied. When the intron is fragmented at position S1 ([Figure 1](#F1){ref-type="fig"}B), the trans-splicing efficiency is the lowest observed (1.66 × 10^−6^; [Figure 5](#F5){ref-type="fig"}, S1). Due to the position of the fragmentation site, at the bottom of the DIV stem, the two intron fragments cannot interact by base pairing but only through long-range tertiary interactions. However, when the intron is fragmented at a position only 19 nt downstream ([Figure 1](#F1){ref-type="fig"}B, S2), the two intron fragments potentially have an additional 16 nt base pair interaction. In this case, sex factor conjugation increases by ∼100-fold (1.44 × 10^−4^; [Figure 5](#F5){ref-type="fig"}, S2). This finding suggests that base pairing between intron fragments plays an important role in intron assembly and splicing *in vivo*, contrary to what was previously proposed from *in vitro* data ([@B6]). Notably, the intron fragments of the vast majority of fragmented group II introns reported kept the potential to interact by a series of base pairs. Even though long range tertiary interactions are expected to be key in the assembly of folded group II intron fragments, it is conceivable that base pairing plays also a role in the assembly of fragmented group II introns at physiological conditions ([@B1]).

The trans-splicing efficiency of Ll.LtrB is greater when the fragmentation in domain IV occurs downstream rather than upstream from the ORF ([Figure 5](#F5){ref-type="fig"}, cf. S3/two fragments to both S1 and S2). A reason for this difference may be that interrupting Ll.LtrB upstream of its ORF can disrupt the DIVa stem ([Figure 1](#F1){ref-type="fig"}B), which is the primary binding site for LtrA ([@B24],[@B34]). Since we showed that the LtrA protein is absolutely necessary for the trans-splicing reaction, it is likely that disruption of its primary interaction site within the intron RNA will decrease trans-splicing efficiency. Therefore, it would be difficult to generalize that group II introns trans-splice more efficiently when fragmented downstream rather than upstream from their carried ORFs within domain IV. Interestingly, a thorough comparative analysis by Qiu and Palmer showed that a mitochondrial group II intron in angiosperms, *nad1i*728, underwent fifteen independent incidences of fragmentation within domain IV throughout differentiation of these species ([@B35]). Among these cases, ten independent fragmentation events occurred upstream of the intron-encoded *matR* gene while only five occurred downstream. However, the authors did not conclude that fragmentation of a group II intron upstream rather than downstream of its carried ORF enabled better trans-splicing.

Since Ll.LtrB showed satisfactory trans-splicing efficiencies when fragmented in domain I and IV independently, we assessed the trans-splicing potential of two tripartite Ll.LtrB introns. We combined one fragmentation within domain IV, upstream or downstream of the ORF, with the fragmentation in domain I ([Figure 1](#F1){ref-type="fig"}B, S2 and S4, S3 and S4). These two tripartite variants of Ll.LtrB failed to trans-splice since the sex factor conjugation efficiency observed was in the 10^−8^ range, which is comparable to overexpression of independent fragments of the relaxase fragmented at sites S3 and S4 ([Figure 5](#F5){ref-type="fig"}). Notably, in chlamydomonas chloroplast, it was shown that at least 9 cellular factors are needed for trans-splicing of the *psaA* tripartite intron ([@B36]). One may imagine that following the fragmentation of a group II intron, the recruitment of splicing factors becomes important in maintaining reasonable splicing efficiency and gene expression.

Using the intron variants fragmented in domain I (S4) and domain IV downstream of the ORF (S3), we show that the LtrA protein is essential for Ll.LtrB trans-splicing *in vivo* ([Figure 5](#F5){ref-type="fig"}). Indeed, trans-splicing of these introns is abolished in the absence of LtrA, and is almost completely restored when LtrA is produced *in trans* from a second plasmid. Interestingly, LtrA remains important for the assembly of Ll.LtrB fragments whether its primary binding site (DIVa) rests in the 5′ or the 3′ intron fragment. These results suggest that for both of these Ll.LtrB fragmented variants, as well as for the ORF-encoding fragmented introns (S1--S5), the LtrA binding structure is correctly folded in a significant proportion of the intron fragments to allow LtrA binding and Ll.LtrB splicing.

It is well established that the maturase activity of the LtrA protein is essential for Ll.LtrB splicing *in vivo* ([@B19],[@B23]). In this study, we demonstrate that the maturase function of LtrA is also extremely important for Ll.LtrB trans-splicing. Using a maturase mutant for the introns fragmented at sites S3 and S4, we observe a significant and consistent drop of ∼35 000-fold in sex factor conjugation efficiency for both constructs ([Figure 5](#F5){ref-type="fig"}, cf. S3/two fragments and S4/two fragments and their respective Mat^−^ counterparts). In our system, it is impossible to use conjugation efficiencies to quantify the difference observed between the cis-splicing full-length intron and its maturase-deficient counterpart since conjugation is saturated when the full-length *ltrB* gene is overexpressed. Yet, one may expect that the assistance of the maturase function of LtrA is more important for bimolecular splicing reactions than for cis-splicing.

We demonstrated that a bacterial group II intron can trans-splice efficiently *in vivo* when fragmented at different positions. Although several splicing-competent fragmented introns were identified in organellar genomes, no trans-splicing group II intron was yet discovered in bacteria. Fragmentation of group II introns through genome rearrangements may occur more readily in organelles than in bacteria. Indeed, numerous trans-splicing group II introns were found in the mitochondrial genomes of higher plants, which are more plastic and subjected to high rearrangement rates ([@B35],[@B37]). Nevertheless, this study suggests that trans-splicing group II introns may exist and eventually be uncovered in prokaryotes. Group II introns can splice *in trans* in bacterial cells and therefore could be maintained if ever generated.
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